dobutamine has been researched along with methylprednisolone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ogawa, R | 1 |
| Hirose, I; Iwao, Y; Masuda, J; Ohashi, T; Sankawa, H; Takaki, H | 1 |
| King, AD; Stewart, JT; Warren, FW | 1 |
| Aronow, WS; Fallon, JT; Frishman, WH; Gass, A; Gupta, T; Khera, S; Kolte, D; Pinnamaneni, S; Singh, T | 1 |
1 review(s) available for dobutamine and methylprednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for dobutamine and methylprednisolone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Methylprednisolone attenuates desensitization to catecholamine after its long-term infusion].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dobutamine; Dopamine; Down-Regulation; Drug Tolerance; Female; Humans; Male; Methylprednisolone; Middle Aged; Receptors, Adrenergic; Time Factors | 1992 |
[Does methylprednisolone potentiate the effects of dobutamine during thoracic epidural analgesia?].
Topics: Anesthesia, Epidural; Dobutamine; Drug Synergism; Female; Humans; Male; Methylprednisolone; Middle Aged | 1991 |
Stability of ranitidine hydrochloride and seven medications.
Topics: Aminophylline; Chromatography, High Pressure Liquid; Dobutamine; Dopamine; Drug Stability; Humans; Lidocaine; Methylprednisolone; Nitroprusside; Norepinephrine; Ranitidine; Sodium Chloride | 1994 |
Back from the brink: catastrophic antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Cardiotonic Agents; Cyclophosphamide; Dobutamine; Extracorporeal Membrane Oxygenation; Female; Heparin; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Mitral Valve Insufficiency; Plasmapheresis; Shock, Cardiogenic; Warfarin | 2015 |